Physician profile
Kim Ly
NPI 1083148571
$1,773.89
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $377 · 2021: $217 · 2022: $285 · 2023: $300 · 2024: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.94 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $775.31 | 2019-2023 | Precision 1, Dailies |
| Glaukos Corporation | $482.57 | 2020-2024 | Idose |
| Bausch & Lomb Americas INC. | $124.98 | 2024 | Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $111.77 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $89.99 | 2024 | Acthar |
| Sun Pharmaceutical Industries INC. | $55.13 | 2024 | |
| Coopervision INC. | $49.08 | 2021 | |
| Astellas Pharma US INC | $28.22 | 2024 | Izervay |
| Novartis Pharmaceuticals Corporation | $27.05 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $16.89 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.